Leaflet TARGIN 15mg / 7.5mg prolonged-release tablets


Indicated for: moderate to severe pain

Substance: oxycodone + naloxone (opioid analgesic + opioid antagonist)

ATC: N02AA55 (Nervous system | Opioids | Natural opium alkaloids)

The combination of oxycodone and naloxone is used for the treatment of severe pain requiring continuous opioid analgesic administration. Oxycodone is a potent opioid analgesic, while naloxone is an opioid antagonist that reduces the risk of opioid-induced constipation.

The medication is taken orally, usually as extended-release tablets, as directed by your doctor. It is important to follow the prescribed dosage to avoid the risk of dependence or other adverse effects.

Side effects may include nausea, drowsiness, dizziness, constipation, or, in rare cases, respiratory depression.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory or liver diseases, to ensure the safe use of this combination.

General data about TARGIN 15mg / 7.5mg

  • Substance: oxycodone + naloxone
  • Date of last drug list: 01-03-2026
  • Commercial code: W61020001
  • Concentration: 15mg / 7.5mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 10
  • Product type: original
  • Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.

Pharmaceutical forms available for oxycodone + naloxone

Concentrations available for oxycodone + naloxone

  • 10mg/5mg
  • 15mg/7.5mg
  • 2.5mg/1.25mg
  • 20mg/10mg
  • 30mg/15mg
  • 40mg/20mg
  • 5mg/2.5mg
  • 60mg/30mg
  • 80mg/40mg